Amikacin (BB-K8) treatment of multiple-drug resistant Proteus infections
- PMID: 4462458
- PMCID: PMC428989
- DOI: 10.1128/AAC.5.5.435
Amikacin (BB-K8) treatment of multiple-drug resistant Proteus infections
Abstract
The new aminoglycoside antibiotic, amikacin (formerly called BB-K8), was used to treat 12 episodes of urinary tract infection caused by hospital-acquired Proteus rettgeri strains. These bacteria were resistant in vitro to kanamycin and gentamicin, and infection persisted in most of the patients in spite of therapy with one of these agents. In all cases, the urinary tract infection was controlled or eradicated by therapy, although relapse or reinfection was frequently encountered in these patients with complicated urological problems. No toxicities attributable to the drug were encountered in the small group of patients.
Similar articles
-
[Amikacin in the treatment of hospital infections of the urinary tract caused by gram-negative bacilli resistant to gentamicin. Microbiological and clinical aspects].Minerva Urol. 1981 Apr-Jun;33(2):85-90. Minerva Urol. 1981. PMID: 7322100 Italian. No abstract available.
-
Treatment of hospita-acquired infections with amikacin.Am J Med. 1977 Jun;62(6):889-93. doi: 10.1016/0002-9343(77)90657-x. Am J Med. 1977. PMID: 868903
-
Comparative study of Amikacin (BB-K8) and gentamicin activity in vitro against Proteus rettgeri.Bol Asoc Med P R. 1977 Jul;69(7):222-6. Bol Asoc Med P R. 1977. PMID: 268183 No abstract available.
-
Antimicrobial spectrum, pharmacology, adverse effects, and therapeutic use of amikacin sulfate.Am J Hosp Pharm. 1981 Jul;38(7):981-9. Am J Hosp Pharm. 1981. PMID: 7020413 Review.
-
An overview of amikacin.Ther Drug Monit. 1985;7(1):12-25. doi: 10.1097/00007691-198503000-00003. Ther Drug Monit. 1985. PMID: 3887667 Review.
Cited by
-
[Clinical efficacy, nephrotoxicity and ototoxicity of amikacin].Infection. 1979;7(2):81-7. doi: 10.1007/BF01641618. Infection. 1979. PMID: 374277 Clinical Trial. German.
-
In vitro activity, synergism, and testing parameters of amikacin, with comparisons to other aminoglycoside antibiotics.Antimicrob Agents Chemother. 1976 Mar;9(3):440-7. doi: 10.1128/AAC.9.3.440. Antimicrob Agents Chemother. 1976. PMID: 1259402 Free PMC article.
-
The effects of hyperbaric oxygen therapy upon ototoxic injuries produced by amikacin in guinea pigs.Braz J Otorhinolaryngol. 2013 May-Jun;79(3):342-8. doi: 10.5935/1808-8694.20130060. Braz J Otorhinolaryngol. 2013. PMID: 23743750 Free PMC article.
-
Penetration of amikacin into the aphakic eye.Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1975 Aug 4;196(1):85-94. doi: 10.1007/BF00410030. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1975. PMID: 1080641
-
Navigating Antibacterial Frontiers: A Panoramic Exploration of Antibacterial Landscapes, Resistance Mechanisms, and Emerging Therapeutic Strategies.ACS Infect Dis. 2024 May 10;10(5):1483-1519. doi: 10.1021/acsinfecdis.4c00115. Epub 2024 May 1. ACS Infect Dis. 2024. PMID: 38691668 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials